Feb 14, 2020 2:28AM EST. AstraZeneca FY19 Core Operating Profit Rises; Sales Up 12% - Quick Facts | NASDAQ. (RTTNews) - AstraZeneca plc (AZN.L, AZN) reported profit before tax of $1.55 billion for the year ended 31 December 2019 compared to $1.99 billion, previous year. Core operating profit was $6.44 billion, an increase of 13%. New medicines represented 42% of total product sales. For fiscal 2020 at CER, depending on the impact of the coronavirus epidemic, AstraZeneca projects: core earnings per share to increase by a mid- to high-teens percentage; and revenue to increase by a high single-digit to a low double-digit percentage.